News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Neumora Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Business
Top Life Sciences Startups to Watch in 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
December 5, 2022
·
15 min read
·
BioSpace Editorial Staff
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Neumora Therapeutics to Participate in Upcoming Conferences in November
November 6, 2024
·
1 min read
Press Releases
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
October 29, 2024
·
1 min read
Press Releases
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
August 15, 2024
·
6 min read
Press Releases
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 6, 2024
·
10 min read
Drug Development
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
May 14, 2024
·
7 min read
Business
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 7, 2024
·
9 min read
Genetown
Neumora Therapeutics to Participate in Upcoming Conferences in May 2024
May 6, 2024
·
1 min read
Drug Development
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 15, 2024
·
5 min read
Genetown
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
March 13, 2024
·
1 min read
Business
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 7, 2024
·
10 min read